You are here

  • Home
  • Archive
  • Volume 77, Issue 11
  • Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab

Article metrics

Article menu
Download PDFPDF
Letter
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab

 

Online download statistics by month:

Online download statistics by month: May 2018 to March 2024

AbstractFullPdf
May 201897415275
Jun 20185564931
Jul 20183161712
Aug 20182714523
Sep 20182283522
Oct 20188188456
Nov 20184774622
Dec 20182352620
Jan 20191762312
Feb 2019188129
Mar 2019203156
Apr 2019135126
May 201912564
Jun 2019133125
Jul 201916863
Aug 2019174125
Sep 20191811411
Oct 2019189108
Nov 201915699
Dec 20191381113
Jan 20201221210
Feb 2020124136
Mar 20208155
Apr 20206833
May 202011165
Jun 20208954
Jul 20205463
Aug 20205346
Sep 20207842
Oct 20208198
Nov 2020132129
Dec 20209584
Jan 20218871
Feb 20219856
Mar 2021101128
Apr 202113152
May 20216553
Jun 2021544
Jul 20211873
Aug 20211032
Sep 20211985
Oct 202197154
Nov 20217232
Dec 202179114
Jan 20228520
Feb 20229375
Mar 202216394
Apr 202295814
May 202216935
Jun 20229622
Jul 2022109168
Aug 202210570
Sep 202217162
Oct 202211341
Nov 20229071
Dec 20225161
Jan 20238120
Feb 202321031
Mar 202310151
Apr 20238221
May 202311063
Jun 20235421
Jul 20236941
Aug 20234262
Sep 20234001
Oct 20237440
Nov 20235321
Dec 20235511
Jan 20249821
Feb 20246033
Mar 2024122113
Total10303898524